So, what does everyone think of the AR?
They’ve got 54M in the bank. MC of 71M.
Milestone payments on Bronchitol of 25M plus 40%-60% of sales later on.
PXS4728A has had 27M Euro already, and another 140M Euro in milestone payments in the pipeline.
Then there’s LOXL2 which I didn’t see any figures against but should be quite big…. (similar to PXS4728a?)
I thought it was all sounding pretty good, but it’s very, very quiet in here.
Anyone got any thoughts?
Ann: Annual Report to shareholders, page-2
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
